Enovis CORP Quarterly Research and Development Expense in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Summary
Enovis CORP quarterly/annual Research and Development Expense history and growth rate from Q2 2010 to Q3 2024.
  • Enovis CORP Research and Development Expense for the quarter ending September 27, 2024 was $20.5M, a 2.97% increase year-over-year.
  • Enovis CORP Research and Development Expense for the twelve months ending September 27, 2024 was $85.7M, a 19.4% increase year-over-year.
  • Enovis CORP annual Research and Development Expense for 2023 was $75.3M, a 23.8% increase from 2022.
  • Enovis CORP annual Research and Development Expense for 2022 was $60.8M, a 23.9% increase from 2021.
  • Enovis CORP annual Research and Development Expense for 2021 was $49.1M, a 43.3% increase from 2020.
Research and Development Expense, Trailing 12 Months (USD)
Research and Development Expense, Quarterly (USD)
Research and Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $85.7M $20.5M +$590K +2.97% Jun 29, 2024 Sep 27, 2024 10-Q 2024-11-06
Q2 2024 $85.1M $23.5M +$4.56M +24.1% Mar 30, 2024 Jun 28, 2024 10-Q 2024-08-07
Q1 2024 $80.5M $23.4M +$5.18M +28.5% Jan 1, 2024 Mar 29, 2024 10-Q 2024-05-02
Q4 2023 $75.3M $18.3M +$3.59M +24.4% Sep 30, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $71.7M $19.9M +$4.3M +27.6% Jul 1, 2023 Sep 29, 2023 10-Q 2024-11-06
Q2 2023 $67.4M $18.9M +$3.26M +20.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $64.2M $18.2M +$3.35M +22.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $60.8M $14.7M +$9.03M +158% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $51.8M $15.6M +$3.14M +25.2% Jul 2, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $48.7M $15.7M +$4.62M +41.9% Apr 2, 2022 Jul 1, 2022 10-Q 2023-08-03
Q1 2022 $44M $14.8M -$5.06M -25.4% Jan 1, 2022 Apr 1, 2022 10-Q 2023-05-04
Q4 2021 $49.1M $5.7M +$20.8M Oct 2, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $28.3M $12.5M -$4.34M -25.8% Jul 3, 2021 Oct 1, 2021 10-Q 2022-11-02
Q2 2021 $32.6M $11M -$3.06M -21.7% Apr 3, 2021 Jul 2, 2021 10-Q 2022-08-04
Q1 2021 $35.7M $19.9M +$1.4M +7.57% Jan 1, 2021 Apr 2, 2021 10-Q 2022-05-10
Q4 2020 $34.3M -$15.1M Oct 3, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $16.8M +$500K +3.07% Jul 4, 2020 Oct 2, 2020 10-Q 2021-11-04
Q2 2020 $14.1M -$18.5M -56.7% Apr 4, 2020 Jul 3, 2020 10-Q 2021-07-28
Q1 2020 $18.5M Jan 1, 2020 Apr 3, 2020 10-Q 2021-04-29
Q3 2019 $16.3M Jun 29, 2019 Sep 27, 2019 10-Q 2020-10-29
Q2 2019 $32.6M Mar 30, 2019 Jun 28, 2019 10-Q 2020-08-06
Q3 2011 $1.44M -$144K -9.1% Jul 2, 2011 Sep 30, 2011 10-Q 2011-10-27
Q2 2011 $1.49M -$27K -1.78% Apr 2, 2011 Jul 1, 2011 10-Q 2011-07-29
Q3 2010 $1.58M Jul 3, 2010 Oct 1, 2010 10-Q 2011-10-27
Q2 2010 $1.52M Apr 3, 2010 Jul 2, 2010 10-Q 2011-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.